Literature DB >> 3034501

Experimental infection of calves with strains of Bovid herpesvirus-4.

G Castrucci, F Frigeri, M Ferrari, S Ranucci, V Aldrovandi, V Cilli, L Rampichini, R Gatti.   

Abstract

Fourteen calves were inoculated intranasally (i.n.) with the viral isolates as follows: 5 with 85/BH 16TV, 1 with 85/BH 17TV, 1 with 85/BH 18TV, 2 with 85/BH 231TN and 5 with 85/BH 232TN. Strain 85/BH 16TV was the only one which caused overt respiratory-like disease in all inoculated calves. Onset of the disease was observed after 7-8 days of incubation and was characterized by fever, depression, nasal discharge and coughing. Virus was isolated from the nasal swabbings of calves obtained from post-infection day (PID) 2-10. The other viral strains did not cause any sign of disease although virus was isolated regularly from the nasal swabbings of the inoculated calves. Virus was recovered from central nervous system tissues of calves that were infected with 85/BH 16TV or 85/BH 232TN strains and were killed on PID 4 or 8. Virus was also isolated from other tissues, such as lymph node, nasal mucosa (PID 8), or lung (PID 4). It was speculated that the nervous system could be one of the target areas of the virus of the naturally occurring infection by BHV-4. This might indicate a possible role of the nervous system (site of latency?) in the pathogenesis of BHV-4 as is the case in certain herpesviral infections of man and the lower animals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034501     DOI: 10.1016/0147-9571(87)90039-7

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  9 in total

1.  Detection of bovine herpesvirus 4 (BoHV-4) DNA in the cell fraction of milk of dairy cattle with history of BoHV-4 infection.

Authors:  G Donofrio; C F Flammini; F Scatozza; S Cavirani
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Molecular typing of a BHV-4 (bovine herpesvirus 4) field isolate.

Authors:  G Donofrio; S Cavirani; C F Flammini; F Scatozza
Journal:  Vet Res Commun       Date:  2000-09       Impact factor: 2.459

3.  Genome sequence and experimental infection of calves with bovine gammaherpesvirus 4 (BoHV-4).

Authors:  Fernando V Bauermann; Shollie M Falkenberg; Mathias Martins; Rohana P Dassanayake; John D Neill; Julia F Ridpath; Simone Silveira; Mitchel V Palmer; Alaine Buysse; Anna Mohr; Eduardo F Flores; Diego G Diel
Journal:  Arch Virol       Date:  2022-06-16       Impact factor: 2.574

4.  Genomic diversity among bovine herpesvirus 4 field isolates.

Authors:  M Bublot; G Wellemans; M F Van Bressem; J Dubuisson; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Molecular cloning and physical mapping of bovine herpesvirus 4 strain DN 599 and comparison with two American field-isolates.

Authors:  D T Shen; D Burger; G Z Tong; J R Gorham
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Rhadinovirus host entry by co-operative infection.

Authors:  Clara Lawler; Ricardo Milho; Janet S May; Philip G Stevenson
Journal:  PLoS Pathog       Date:  2015-03-19       Impact factor: 6.823

7.  Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs.

Authors:  Miriam Pedrera; Francesca Macchi; Rebecca K McLean; Valentina Franceschi; Nazia Thakur; Luca Russo; Lobna Medfai; Shawn Todd; Elma Z Tchilian; Jean-Christophe Audonnet; Keith Chappell; Ariel Isaacs; Daniel Watterson; Paul R Young; Glenn A Marsh; Dalan Bailey; Simon P Graham; Gaetano Donofrio
Journal:  Vaccines (Basel)       Date:  2020-03-02

8.  Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function.

Authors:  Gaetano Donofrio; Shan Herath; Chiara Sartori; Sandro Cavirani; Cesidio Filippo Flammini; Iain Martin Sheldon
Journal:  Reproduction       Date:  2007-07       Impact factor: 3.906

9.  Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.

Authors:  Gaetano Donofrio; Chiara Sartori; Lara Ravanetti; Sandro Cavirani; Laurent Gillet; Alain Vanderplasschen; Simone Taddei; Cesidio Filippo Flammini
Journal:  BMC Biotechnol       Date:  2007-10-18       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.